Cargando…

The added value of PSMA PET/MR radiomics for prostate cancer staging

PURPOSE: To evaluate the performance of combined PET and multiparametric MRI (mpMRI) radiomics for the group-wise prediction of postsurgical Gleason scores (psGSs) in primary prostate cancer (PCa) patients. METHODS: Patients with PCa, who underwent [(68) Ga]Ga-PSMA-11 PET/MRI followed by radical pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solari, Esteban Lucas, Gafita, Andrei, Schachoff, Sylvia, Bogdanović, Borjana, Villagrán Asiares, Alberto, Amiel, Thomas, Hui, Wang, Rauscher, Isabel, Visvikis, Dimitris, Maurer, Tobias, Schwamborn, Kristina, Mustafa, Mona, Weber, Wolfgang, Navab, Nassir, Eiber, Matthias, Hatt, Mathieu, Nekolla, Stephan G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803696/ https://www.ncbi.nlm.nih.gov/pubmed/34255130 http://dx.doi.org/10.1007/s00259-021-05430-z

Ejemplares similares

Is there more than meets the eye in PSMA imaging in prostate cancer with PET/MRI? Looking closer at uptake time, correlation with PSA and Gleason score
por: Bogdanovic, Borjana, et al.
Publicado: (2023)

Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patients
por: Bogdanovic, Borjana, et al.
Publicado: (2020)

Value of PET ECG gating in a cross-validation study of cardiac function assessment by PET/MR imaging
por: Villagran Asiares, Alberto, et al.
Publicado: (2022)

Whole-body uptake classification and prostate cancer staging in (68)Ga-PSMA-11 PET/CT using dual-tracer learning
por: Capobianco, Nicolò, et al.
Publicado: (2021)

Gating failure can result in underestimation of cardiac function in myocardial perfusion scintigraphy
por: Villagran Asiares, Alberto, et al.
Publicado: (2020)

Pre-test (68)Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model
por: Kraft, Pia, et al.
Publicado: (2020)

Multicentric validation of radiomics findings: challenges and opportunities
por: Hatt, Mathieu, et al.
Publicado: (2019)

A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients
por: Peeken, Jan C., et al.
Publicado: (2020)

Evaluation of SUV normalized by lean body mass (SUL) in (68)Ga-PSMA11 PET/CT: a bi-centric analysis
por: Gafita, Andrei, et al.
Publicado: (2019)

The value of (68)Ga-PSMA enhanced PET-CT and MR-PET in patients with biochemical recurrent prostate cancer
por: Rummeny, E, et al.
Publicado: (2015)

PSMA-targeted imaging of prostate cancer: evolution of a success story
por: Maurer, Tobias, et al.
Publicado: (2017)

[(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery
por: Schottelius, Margret, et al.
Publicado: (2015)

PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy
por: Wang, Hui, et al.
Publicado: (2021)

(68)Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
por: Rauscher, Isabel, et al.
Publicado: (2016)

Heterogeneity of prostate-specific membrane antigen (PSMA) and PSMA-ligand uptake detection combining autoradiography and postoperative pathology in primary prostate cancer
por: Wang, Hui, et al.
Publicado: (2023)

Measuring the expansion of myocardial extracellular volume using quantitative perfusion imaging: Validation with T1 mapping and simultaneous (18)FDG-PET in patients after acute myocardial infarction
por: Kunze, Karl P, et al.
Publicado: (2015)

MRI-Derived Radiomics to Guide Post-operative Management for High-Risk Prostate Cancer
por: Bourbonne, Vincent, et al.
Publicado: (2019)

Preclinical biodistribution and dosimetry and human biodistribution comparing (18)F-rhPSMA-7 and single isomer (18)F-rhPSMA-7.3
por: Knorr, Karina, et al.
Publicado: (2022)

Comparison and Fusion of Machine Learning Algorithms for Prospective Validation of PET/CT Radiomic Features Prognostic Value in Stage II-III Non-Small Cell Lung Cancer
por: Sepehri, Shima, et al.
Publicado: (2021)

Transcriptomics in cancer revealed by Positron Emission Tomography radiomics
por: Tixier, Florent, et al.
Publicado: (2020)

Accurate Tumor Delineation vs. Rough Volume of Interest Analysis for (18)F-FDG PET/CT Radiomics-Based Prognostic Modeling inNon-Small Cell Lung Cancer
por: Sepehri, Shima, et al.
Publicado: (2021)

External Validation of a Radiomics Model for the Prediction of Complete Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
por: Bordron, Anaïs, et al.
Publicado: (2022)

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
por: Spohn, Simon K. B., et al.
Publicado: (2023)

Generation of pseudo-CT from a single MRI for PET/MR attenuation correction purposes
por: Monnier, Florian, et al.
Publicado: (2014)

Classification of Polar Maps from Cardiac Perfusion Imaging with Graph-Convolutional Neural Networks
por: Spier, Nathalia, et al.
Publicado: (2019)

Development of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer Patients
por: Bourbonne, Vincent, et al.
Publicado: (2021)

Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with (177)Lu-PSMA I&T therapy
por: Xue, Song, et al.
Publicado: (2022)

PSMA-PET for Lymph Node Detection in Recurrent Prostate Cancer: How do we use the Magic Bullet?
por: Maurer, Tobias, et al.
Publicado: (2017)

Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET
por: Leung, Kevin H., et al.
Publicado: (2022)

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
por: Gafita, Andrei, et al.
Publicado: (2022)

Pitfalls in PSMA imaging: [(18)F]rhPSMA-7-PET/CT reveals presence of chrondrosarcoma
por: Feuerecker, B., et al.
Publicado: (2021)

Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical Cancer
por: Lucia, François, et al.
Publicado: (2021)

A transfer learning approach to facilitate ComBat-based harmonization of multicentre radiomic features in new datasets
por: Da-ano, Ronrick, et al.
Publicado: (2021)

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer
por: Staniszewska, Magdalena, et al.
Publicado: (2021)

EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer
por: Falkenbach, Fabian, et al.
Publicado: (2023)

Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using (68)Ga-FAPI-04
por: Notohamiprodjo, Susan, et al.
Publicado: (2021)

2021: the year [(177)Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines?: Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
por: Herrmann, Ken, et al.
Publicado: (2021)

Non rigid respiratory motion correction in whole body PET/MR imaging
por: Fayad, Hadi, et al.
Publicado: (2014)

Influence of sampling schedules on [(177)Lu]Lu-PSMA dosimetry
por: Rinscheid, Andreas, et al.
Publicado: (2020)

Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with (177)Lu-PSMA
por: Moazemi, Sobhan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tvgce333mo4ej0q8sotgdeui4s